Advertisement

European Journal of Pediatrics

, Volume 134, Issue 3, pp 245–248 | Cite as

Haemostatic changes in tall girls treated with high doses of ethinyloestradiol

  • W. Muntean
  • M. Borkenstein
Original Investigations

Abstract

Haemostasis was studied in 8 tall girls during treatment with high doses of synthetic oestrogens for a period of 1 to 28 months. The girls received 0.5 mg ethinyloestradiol daily from day 1 to day 25 and 15 mg norethisteron daily from day 21 to day 25. All were without clinical signs of thromboembolism.

Factors of the prothrombin complex were significantly elevated in the tall girls compared to healthy controls of the same age. Fibrinogen was also significantly elevated. Factor VIII-related antigen was significantly higher in the tall girls and the ratio between factor VIII activity and factor VIII-related antigen was significantly decreased in the tall girls, as compared to the controls. Thrombin time was significantly shortened. Tests of primary haemostasis showed an increased tendency for thrombocytes to adhere to glass and to aggregate spontaneously and after stimulation with ADP or collagen.

Whether these in vitro signs of hypercoagulability indicate an enhanced risk of thromboembolic complications in tall girls treated with high doses of oestrogens remains to be established. However, these girls should to be watched carefully for clinical signs of thromboembolic complications during treatment.

Key words

Tall girls Ethinyloestradiol treatment Alterations of the blood clotting system 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asbeck F, Lechler E, van de Loo J (1971) Das Verhalten des fibrinolytischen Systems unter Östrogen-Gestagen-Kombination. Thrombos Diathes haemorrh, Suppl 133:48–50Google Scholar
  2. Atkins P, Brown IK, Downie RJ, Haggart BG, Litten J, Robb PM, Santer GJ, Jones I (1978) The value of phenformin and ethyloestrenol in the prevention of deep venous thrombosis in patients undergoing surgery. Thrombos Haemostas 39:89Google Scholar
  3. Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat 17:237Google Scholar
  4. Danforth D, Manalo-Estrella P, Buckingham J (1964) The effect of pregnancy and of Enovid on the rabbit vasculature. Amer J Obstet Gynec 88:952Google Scholar
  5. Davies T, Fieldhouse G, McNicol GP (1976) The effects of therapy with oestriol succinate and ethinyl oestradiol on the haemostatic mechanism in post-menopausal women. Thrombos Haemostas 35:403Google Scholar
  6. Dettori AG (1979) Haemostatic changes associated with hormonal contraceptive treatment. Thrombos Haemostas 42: 24Google Scholar
  7. Drill VA, Calhoun DW (1972) Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives. J Amer med Ass 219:593Google Scholar
  8. Fagerhol MK, Abildgaard U (1970) Immunological studies on human antithrombin III. Scand J Haemat 7:10Google Scholar
  9. Goodrich SM, Wood JE (1966) The effect of estradiol 17-beta on peripheral venous distensibility and velocity of venous blood flow. Amer J Obstet Gynec 96:407Google Scholar
  10. Hedlin AM (1975) The effect of oral contraceptive oestrogen on blood coagulation and fibrinolysis. Thromb Diathes haemorrh 33:370Google Scholar
  11. Hedner U, Nilsson IM (1973) Antithrombin III in a clinical material. Bibl Anat 12:267Google Scholar
  12. Hougie C, Rutherford RN, Banks AL, Coburn WA (1965) Effect of a progestin-estrogen oral contraceptive on blood clotting factors. Metabolism 14:411Google Scholar
  13. Inman WH, Vessey MP, Westerholm B, Engelund A (1970) thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Brit med J II:203Google Scholar
  14. Kaulla E v, Droegenmüller W, Kaulla KN v (1972) Die Wirkung von oralen Kontrazeptiva und Östrogenen auf die Antithrombin-III-Aktivität und andere Gerinnungsparameter. Thrombos Diathes haemorrh Suppl 50:113Google Scholar
  15. Kuhn N, Blunck W., Stahnke N, Wibel J, Willig RP (1977) Oestrogen treatment in tall girls. Acta paed Scand 66:161Google Scholar
  16. Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 14:45Google Scholar
  17. Ludwig H (1972) Nebenwirkungen von Ovulationshemmern auf Blutgerinnung, Kreislauf und Stoffwechsel. Internist 13:286Google Scholar
  18. Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigen by single radial immunodiffusion. Immunochemistry 2:235Google Scholar
  19. McKenna R, Wu KK, Smith C, Sweet J, Ku C (1979) Effect of 17 a ethynylestradiol on platelet sialic acid and platelet aggregability. Thrombos Haemostas 52:25Google Scholar
  20. Miller SP, Lee SL, Ritz N (1965) Progestin-estrogen (SC II, 800) therapy and the haemostatic mechanism—a controlled study. Metabolism 14:398Google Scholar
  21. Nilsson IM (1974) Haemorrhagic and thrombotic diseases. John Wiley and Sons, London, p. 69Google Scholar
  22. Poller L, Thomson JM (1966) Clotting factors during oral contraception: further report. Brit Med J II:23Google Scholar
  23. Poller L, Thomson JM, Coope J (1977) Conjugated equine oestrogens and blood clotting: a follow-up report. Brit Med J I:935Google Scholar
  24. Sabra AMA, Bonnar J (1979) Comparable effects of 30 and 50 mcg oestrogen/progestogen oral contraceptives on blood clotting and fibrinolysis. Thromb Haemostas 42:25Google Scholar
  25. Sutor AH, Schäuble R, Frede-Schweder I (1978) Ein neuer Vollblut-Plättchen-Aggregationstest. Standardisierung und klinisch-pädiatrischer Anwendungsbereich. In: Breddin HK (Hrsg) Prostaglandine nd Plättchenfunktion, Schattauer, Stuttgart New York, pp 143–140Google Scholar
  26. Todd AS (1959) The histological localization of fibrinolysin activitor. J Path Bact 78:281Google Scholar
  27. Vessey MP, Doll R (1968) Investigation of relation between use of oral contraceptives and thromboembolic diseases. Brit Med J II:199Google Scholar
  28. Wright HD (1941) The adhesivness of blood platelets in normal subjects with varying concentrations of anticoagulants. J Path Bact 52:255Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • W. Muntean
    • 1
  • M. Borkenstein
    • 1
  1. 1.Department of PediatricsUniversity of GrazGrazAustria

Personalised recommendations